Daniel K. Podolsky net worth and biography

Daniel Podolsky Biography and Net Worth

Director of Agilent Technologies

Daniel K. Podolsky is the founder of The Gi Co., Inc. He currently holds several positions including Independent Director at Agilent Technologies, Inc., Director at Southwestern Medical Foundation, Member-National Academy of Medicine at the National Academy of Sciences, Member at the National Academy of Medicine (United States), and Member at the Council of Teaching Hospitals. Since 2008, he has been serving as the President of The University of Texas Southwestern Medical Center. In the past, he has worked as an Independent Non-Executive Director at Genelabs Technologies, Inc., GSK Plc, and Antibe Therapeutics, Inc. He has also held positions such as Chief Gastroenterology at The General Hospital Corp., Chief Academic Officer & Dean at Mass General Brigham, Inc., President of the American Gastroenterological Association, and Professor at Harvard Medical School.

Dr. Podolsky obtained his doctorate degree from Harvard University.

What is Daniel K. Podolsky's net worth?: The estimated net worth of Daniel K. Podolsky is at least $3.57 million as of March 31st, 2025. Podolsky owns 35,737 shares of Agilent Technologies stock worth more than $3,565,338 as of April 10th. This net worth estimate does not reflect any other investments that Podolsky may own. Learn More about Daniel K. Podolsky's net worth.
How do I contact Daniel K. Podolsky?: The corporate mailing address for Podolsky and other Agilent Technologies executives is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. Agilent Technologies can also be reached via phone at (800) 227-9770 and via email at investor_relations@agilent.com. Learn More on Daniel K. Podolsky's contact information.
Has Daniel K. Podolsky been buying or selling shares of Agilent Technologies?: Daniel K. Podolsky has not been actively trading shares of Agilent Technologies over the course of the past ninety days. Most recently, Daniel K. Podolsky sold 1,819 shares of the business's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a transaction totalling $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares of the company's stock, valued at $4,161,931.02. Learn More on Daniel K. Podolsky's trading history.
Who are Agilent Technologies' active insiders?: Agilent Technologies' insider roster includes Henrik Ancher-Jensen (SVP), Philip Binns (SVP), Heidi Fields (Director), Rodney Gonsalves (VP), Dominique Grau (SVP), Boon Koh (Director), Padraig Mcdonnell (Chairman of the Board & CEO), Michael Mcmullen (CEO), Daniel Podolsky (Director), Samraat Raha (VP), Michael Tang (SVP), and Jacob Thaysen (VP). Learn More on Agilent Technologies' active insiders.
Are insiders buying or selling shares of Agilent Technologies?: In the last twelve months, insiders at the medical research company sold shares 9 times. They sold a total of 36,549 shares worth more than $4,998,598.58. The most recent insider tranaction occured on March, 31st when Director Daniel K Podolsky sold 1,819 shares worth more than $211,840.74. Learn More about insider trades at Agilent Technologies.
Information on this page was last updated on 3/31/2025.

Daniel K. Podolsky Insider Trading History at Agilent Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/31/2025	Sell	1,819	$116.46	$211,840.74	35,737

Daniel K. Podolsky Buying and Selling Activity at Agilent Technologies

Agilent Technologies Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Today's Range

Now: $99.77

$96.81

$105.28

50 Day Range

MA: $124.64

$98.97

$147.92

2 Week Range

Now: $99.77

$96.43

$155.35

Volume

4,977,803 shs

Average Volume

1,847,192 shs

Market Capitalization

$28.44 billion

P/E Ratio

22.93

Dividend Yield

1.00%

Beta

1.19